Shows
WCG Talks TrialsHealth Literacy in Action: The Impact of Plain Language Communication in Clinical ResearchIn this episode of WCG Talks Trials, Sandy Smith, Sylvia Baedorf Kassis, and Dr. Donna Snyder discuss the critical role of health literacy in clinical research. They explore how clear communication can enhance patient understanding and engagement, the importance of a common language in research, and the introduction of the MRCT Center’s Clinical Research Glossary as a tool to facilitate better communication. The conversation emphasizes the need for consistent terminology and the integration of health literacy practices in clinical research to improve participant experiences and outcomes.Key highlights:Health literacy is crucial for ef...
2025-10-0928 minWCG Talks TrialsAdvancing Access: How SaaS is Transforming Clinical TrialsIn this episode of WCG Talks Trials, Cristin MacDonald, Doug Mayer, and Tyler Bye discuss how Software as a Service (SaaS) solutions are democratizing the clinical trial landscape. Learn how SaaS platforms are enabling organizations of all sizes to leverage cutting-edge technology, improving collaboration, standardization, and data security throughout the clinical research process. The team shares the benefits of adopting SaaS, practical insights for successful implementation, and highlights the pivotal role of technology partnerships in supporting innovation and research efficiency. Tune in to discover how your organization can optimize clinical trials and accelerate research impact with SaaS technology.
2025-08-2623 min
Creating RelevanceKunst als ImpulsgeberIn dieser Folge sprechen wir mit Jan Welke, Gesellschafter der WCG, sowie Dr. Walter Smerling, Direktor des Museums Küppersmühle für moderne Kunst. Erfahren Sie mehr über die Sichtweisen der beiden über das große Oberthema der Kunst und warum es für sie eine große Relevanz in Unternehmen hat!
2025-08-2637 minWCG Talks TrialsAdvancing Imaging in Clinical Trials Using AIIn this episode of WCG Talks Trials, Silvio Galea, chief data and analytics officer, and Bryan Wayne, vice president of imaging operations, both of WCG, explore the critical role of imaging in clinical trials. Together, they break down industry acronyms, unpack the process of independent image review, and discuss how WCG is contributing to the validation and implementation of AI-driven radiology solutions. Listen in as they share behind-the-scenes insights into core lab operations, the significance of sample size and study design, and how emerging technology is shaping the future of clinical research. Whether you are a clinical trial professional...
2025-08-0621 min
Creating RelevanceZukunft aktiv gestaltenIn dieser Folge sprechen wir mit Nicole Bauer, Geschäftsführerin von Talentscout, und Lucia Peter, Senior Consultant bei der WCG. Gemeinsam geben sie Einblicke in aktuelle Entwicklungen rund um Fachkräftemangel, Unternehmenskultur und Employer Branding.
2025-06-2632 minWCG Talks TrialsFuture-Ready Research: Optimizing Sites for Continued SuccessIn this episode of WCG Talks Trials, Sandy Smith, senior vice president, clinical solutions & strategic partnering, WCG, is joined by Tiffany Pierce, director, clinical trials core, Henry Ford Health System, to discuss resilience in clinical research.As the landscape of clinical trials faces evolving challenges, they explore how organizations and institutions, like Henry Ford Health, are addressing disruptions, uncertainties, and changes at the federal level. Learn about innovative strategies to enhance trial efficiency, including role clarity, flexible workflows, and diversifying research portfolios.With a focus on maintaining forward momentum in trials and remaining nimble, they...
2025-06-2020 minWCG Talks TrialsHarnessing Generative AI in Clinical ResearchDive into the world of generative AI with Silvio Galea, chief data analytics officer, WCG, and Kyle Miller, lead data scientist, WCG. In this compelling episode of WCG Talks Trials, we explore how Generative AI can improve clinical research workflows from meticulous data entry to efficient data validation. Uncover the technology behind AI’s ability to assist in document updates, highlight transcription biases, and digitize complex data for predictive analytics. Understand the importance of human oversight and practical applications that can optimize how clinical trials are conducted. Whether you’re curious about AI’s role in reading dense documents or lev...
2025-05-2823 min
Creating RelevanceDie Kraft der OrganisationKonzepte, Teams und Strukturen neu denken
Wenn ihr mehr zum Thema erfahren möchtet, besucht unsere Website https://www.wcg.de/podcast-die-kraft-der-organisation/ und lasst euch empowern!
2025-03-1918 minWCG Talks TrialsAI in Clinical Trials: Unlocking the PotentialIn this episode of WCG Talks Trials, join Silvio Galea, chief data and analytics officer, WCG, and Melissa Hutchens, vice president of research and benchmarking, WCG, as they discuss the transformative role of AI in clinical trials. Discover how generative AI and other AI technologies are enhancing the quality of clinical trials, reducing cycle times, and cutting costs. The episode covers the benefits, barriers, and concerns associated with AI, and explores its applications in drug discovery, participant recruitment, trial design, and more. Tune in to learn about the latest advancements in AI and how they are shaping the future...
2025-03-1827 minWCG Talks TrialsBreaking Down Site Complexities and Start-Up Barriers in Clinical TrialsJoin us for "Breaking Down Site Complexities and Start-Up Barriers in Clinical Trials" as we uncover the complexities of site management and the barriers to effective study start-ups. Discover the top issues impacting research sites and strategies to overcome them, including trial complexity, start-up hurdles, and long initiation timelines. Learn how effective communication, teamwork, and clear processes can drive success, and the importance of human connections and inclusivity in clinical research. Get practical advice for improving site readiness and trial efficiency from our expert guests. Don't miss this essential episode on navigating the evolving clinical tr...
2025-02-2425 minWCG Talks TrialsFrom Patient Care to Discovery: A Clinician's Journey into ResearchJoin us for a compelling episode of WCG Talks Trials where we take a look into the rewarding world of clinical trials and clinical development. In this episode, George Cokenakes, director of clinical services, review solutions, WCG, speaks with Dr. James Januzzi, a renowned cardiologist at Massachusetts General Hospital, and chief scientific officer at Baim Institute for Clinical Research. Dr. Januzzi shares his inspiring journey, highlighting the significance of clinical trial participation and the diverse opportunities that can shape a medical career. Learn from Dr. Januzzi's extensive experience in clinical research, including his work on cardiac biomarkers, d...
2024-12-1019 minWCG Talks TrialsInside MAGI: Innovation, Education, and Industry TrendsIn this episode of "WCG Talks Trials," host Geoffrey Schick, director of strategic site partnerships, WCG, is joined by fellow MAGI@home 2024 speakers Sandy Smith, Jess Thompson, and Wesley Warren. They share their unique perspectives and key takeaways from this year's virtual conference, including discussions on contract negotiations, the evolving role of advanced practice practitioners, and the collaborative panels featuring both site and sponsor/CRO insights. The episode also recaps the impactful session on the FDA's Diversity Action Plan and what it means for the future of clinical trials. Tune in to hear about the dynamic energy, valuable connections...
2024-11-2529 minWCG Talks TrialsRevolutionizing Clinical Research Through Collaboration and InnovationIn this episode of WCG Talks Trials, host Sandy Smith, senior vice president of clinical solutions and strategic partnering at WCG, dives into the highlights of the Florence Healthcare Research Revolution event. Sandy is joined by industry experts Andrea Bastek, vice president of innovation at Florence, and Lauren Sobocinski, senior vice president of strategic alliances at WCG, to discuss transformative insights from the event. Discover the latest trends shaping clinical research, including site engagement, protocol complexity, and effective sponsor-site relationships. Tune in for a compelling discussion on how collaborative efforts and innovative technologies are driving positive change in the...
2024-11-0728 min
Creating RelevanceDer Geschmack von Verantwortung120 Jahre - Tradition trifft auf Innovation
Wenn ihr mehr zum Thema "Tradition & Innovation" erfahren möchtet, besucht unsere Website https://www.wcg.de/podcast/der-geschmack-von-verantwortung/ und lasst euch empowern!
2024-10-3133 minWCG Talks TrialsHave a Safe Trip: Clinical and Patient Alignment in Research with PsychedelicsIn this episode of WCG Talks Trials, host Kelly FitzGerald sits down with Dr. Currien MacDonald, Medical Chair Director at WCG, and Sara Reed, a participant in two psychedelic clinical trials, to explore the evolving landscape of psychedelics research. Dr. MacDonald shares his expertise on the growing acceptance of psychedelics in clinical settings, recent FDA updates, and the inner workings of ongoing trials. Later, Sara provides a firsthand account of her experiences as a trial participant, offering unique insights into how psychedelics are being tested as potential therapeutic options. Tune in to learn more about aligning clinical practice with...
2024-10-0723 minWCG Talks TrialsBreaking Barriers: Reasons to Expand Site Cancer Trial PortfoliosIn this episode of WCG Talks Trials, Geoff Schick, director of strategic site partnerships, joins our host Sandy Smith, senior vice president of clinical solutions and strategic partnering, to discuss the expansion of research site cancer portfolios.
2024-09-1828 minWCG Talks TrialsPatient Advocacy Advancing Breakthrough Science and Community EngagementJoin Desiree Underwood-Williams, director of project management organization at WCG and guest Steve Smith, CEO of SteveSmithPlans LLC and facilitator of the WCG Patient Forum, as they recap the latest Patient Forum Focus Session on breakthrough science and community engagement. Discussion highlights include:The impact of medical diagnoses on families with Sickle cell disease and melanoma.New research in cell and gene therapy that’s directly impacting Sickle cell disease and melanoma patients.New diversity laws shaping the future of drug development.Community engagement and how patients can get involved in their care.And more insights into the WCG...
2024-09-1628 minWCG Talks TrialsGuarding Research Integrity: The IRB's Essential Role In this episode of WCG Talks Trials, we are joined by host Joanne Thomas, clinical reviewer and patient advocate at WCG, along with our guest Currien MacDonald, medical chair director at WCG. This episode covers the roles of IRB in ethical clinical research, frequently asked questions, and a general overview of the IRB’s role in clinical trials.
2024-09-1327 minWCG Talks TrialsAddressing Challenges in Site FeasibilityThis episode of WCG Talks Trials addresses site feasibility challenges impacting the clinical trials industry. Join Michelle Yu, associate director of clinical strategy at WCG, and our guest Trevor Cole, director of client delivery, site and strategic operations for WCG, as we discuss approaches to adopt innovative feasibility and site start-up solutions.Here are links to documents referenced in this episode:Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research StatementMain Article: https://ascopubs.org/doi/10.1200/OP.20.00821 PDF Data Supplement: https://society.asco.org/sites/new-www.asco.org/f...
2024-08-3020 min
Creating RelevanceInner Compass: Der Antrieb zum ErfolgEine Reise zur Selbsterkenntnis und zur Definition des Warums hinter jedem unternehmerischen Schritt
Wenn ihr mehr zum Thema "Inner Compass" erfahren möchtet, besucht unsere Website https://www.wcg.de/podcast-inner-compass/ und lasst euch empowern!
2024-07-2424 min
Creating RelevanceB2B-Marketing als GamechangerWarum der Mensch im digitalen Zeitalter wichtiger denn je ist
Wenn ihr mehr zum Thema "Erfolgreiches B2B Marketing" erfahren möchtet, besucht unsere Website https://www.wcg.de/b2b-marketing-als-gamechanger/ und lasst euch empowern! Das Whitepaper könnt hier kostenlos downloaden: https://hubspot.wcg.de/de-de/im-gleichtakt-zum-erfolg-0
2024-06-2731 minWCG Talks TrialsEthical Review and AI in Clinical TrialsJoin our Chief Analytics Officer Silvio Galea, along with Dr. Donna Snyder & Dr. Barbara Bierer to discuss opportunities on the ethical and regulatory challenges regarding artificial intelligence in clinical trials. The discussion is focused through the lens of the IRB review, and how a multi-stakeholder task force led by the Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and WCG will address the growing need for guidance in this rapidly evolving area of research.
2024-06-2139 minWCG Talks TrialsAddressing Measurement Challenges for PTSD Trials with TechnologyIn this episode of WCG Talks Trials, we are joined by WCG clinical science experts as they discuss traditional measurement challenges for PTSD trials and how the use of an electronic CAPS-5 scale is improving administration and scoring errors. Tune in as we discuss the CAPS-5 scale, the opportunities and benefits of using an electronic version to help standardize scale administration and scoring across clinical research, and the promising results to date.
2024-06-1121 min
Creating RelevanceDie Kunst familiengeführter UnternehmenEin Blick hinter die Kulissen der Isabella Glutenfreien Pâtisserie
Wenn ihr mehr zum Thema "Familienunternehmen & Wachstum" erfahren möchtet, besucht unsere Website https://www.wcg.de/podcast-die-kunst-familiengefuehrter-unternehmen/ und lasst euch empowern!
2024-05-0323 min
Creating RelevanceFördermittel beherrschenFördermittel und Bürokratie: Tipps für Unternehmer
Wenn Sie mehr über die verschiedenen Fördermittel erfahren und die Bürokratie überwinden möchten, besuchen Sie unsere Website https://www.wcg.de/podcast-foerdermittel-beherrschen-tipps-fuer-unternehmer/ und lassen Sie sich inspirieren!
2024-04-1117 min
Creating RelevanceEin Jahrhundert der InnovationDer Aufstieg zur Erfolgsmarke: Das Unternehmen Herchenbach
Wenn Sie mehr über die Erfolgs Geschichte des lokalen Unternehmens "Herchenbach" erfahren möchten, besuchen Sie unsere Website https://www.wcg.de/podcast-ein-jahrhundert-der-innovation/ und lassen Sie sich inspirieren!
2024-03-2129 minWCG Talks TrialsCreating Partnerships: Aligning Vendor Support for Success in Clinical ResearchIn the most recent episode of WCG Talks Trials, we are joined by three industry experts, Amy Thue and Shelby Ward from WCG, and Russell Lampman from Merck to discuss the topic of optimizing vendor support, and ultimately the success, of clinical trials.Listen in as we dive into feedback and perspectives from both the sponsor and vendor side of the table—for valuable take-aways and insights into how vendor support is best aligned across all stakeholders.
2024-03-0620 minWCG Talks TrialsWCG's IRB Policy Change: Harmonizing Consent (Part 2)In Part 2 of this discussion, Currien MacDonald, MD, CIP Medical Chair Director for WCG's IRB, discusses new FDA regulations for waiver of consent with Kelly Fitzgerald, PhD, WCG's IRB Executive Chair and VP IBC Affairs.
2024-02-2708 minWCG Talks TrialsWCG's IRB Policy Change: Harmonizing Consent (Part 1)In Part 1 of this discussion, Currien MacDonald, MD, CIP Medical Chair Director for WCG's IRB, discusses a policy change that is going into effect for WCG IRB with Lindsay Abrahams, Regulatory Chair Director. Lindsay and Currien discuss the concise summary and its application to consent forms, especially for WCG.
2024-02-2706 min
Creating RelevanceDer Weg zur MeisterschaftBeratung und Training in Unternehmen – Was führt zum Erfolg?
Wenn ihr mehr zum Thema "Beratung & Training - Der Weg zum Unternehmenserfolg" erfahren möchtet, besucht unsere Website https://www.wcg.de/podcast-der-weg-zur-meisterschaft und lasst euch empowern!
2024-02-0812 min
Creating RelevanceAlles läuft digital, oder nicht?E-Commerce in B2B Unternehmen - Wie kann die Zukunft sinnvoll gestaltet werden?
Wenn ihr mehr zum Thema "E-Commerce in B2B-Unternehmen" erfahren möchtet, besucht unsere Website https://www.wcg.de/podcast-alles-laeuft-digital-oder-nicht/ und lasst euch empowern!
2024-01-1822 minWCG Talks TrialsThe Ethical and Safety Considerations of Accelerating Oncology TrialsIn this episode of WCG Talks Trials, our expert panel discusses various ethical, safety, and logistical challenges in accelerating clinical trials for gene and cell therapies in oncology. The conversation explores the role of Institutional Review Boards (IRBs), Institutional Biosafety Committees (IBCs), Endpoint Adjudication Committees (EACs), and Data Monitoring Committees (DMCs) in overseeing these trials, addressing issues such as patient safety, complex trial designs, and emerging biosafety concerns. Our panelists emphasize the importance of transparent communication and collaboration between IRBs and IBCs, highlighting the need to balance the urgency of advancing research with ethical considerations. Additionally, the podcast explores...
2024-01-1643 minWCG Talks TrialsEmbarking on a Research Revolution – A Conversation with Florence HealthcareIn episode 10 of WCG Talks Trials, we are joined by Catherine Gregor, the Chief Clinical Trial Officer at Florence Healthcare, to discuss Florence’s recent Research Revolution event and the importance of site enablement in clinical research. Listen in as we recap Research Revolution, share insights on emerging clinical trial trends and innovations, and have a candid conversation about what stands in the way of successful site enablement in clinical research.
2023-12-1830 minWCG Talks TrialsThe CRA’s Evolving Role in a Postpandemic IndustryIn this episode of WCG Talks Trials, we are joined by Elizabeth Weeks-Rowe, CCRA, author of The CRA’s Guide to Monitoring Clinical Research, 6th Edition.Led by WCG Director of Publications and Content, Leslie Ramsey, the discussion will delve into the ways the clinical trials industry has become more complex and technologically focused and the challenges clinical research associates (CRAs) face as monitors of clinical trials.Host: Leslie Ramsey, Director of Publications and Content, WCG Participant: Elizabeth Weeks-Rowe, Independent Clinical Research Consultant
2023-12-1436 minWCG Talks TrialsMAGI@home: Practical Intelligence, Real-life Examples, Actionable InformationIn this episode of WCG Talks Trials, we are joined by MAGI@home Steering Committee members, Jennifer Peterson, Director, Head of Clinical Quality at M3 Wake Research, and Geoffrey Schick, Director, Strategic Site Partnerships at WCG. Led by Carmin Gade, Chief Marketing Officer at WCG, the discussion will delve into the insights and value MAGI events provide that enable attendees to achieve success in their roles and professional development.
2023-12-0429 minWCG Talks TrialsDiversity & Inclusion with Technology in Decentralized TrialsThis episode of WCG Talks Trials, hosted by Kelly Fitzgerald, Executive IRB Chair and Vice President of IBC Affairs at WCG, dives into the topic of diversity and inclusion with technology in decentralized clinical trials (DCTs). The episode explores the transformative opportunities that DCTs present for addressing diversity gaps in clinical research. The discussion features a panel of experts, including Otis Johnson, former Chief Diversity, Inclusion, and Sustainability Officer at Clario; Archana Sah, a seasoned clinical development leader with a focus on oncology and healthcare technology; and Ken McCann, a physician with a background in pediatrics and a keen...
2023-11-221h 05WCG Talks TrialsAmplifying Patient Voices to Advance Clinical Research: The Importance of Patient AdvocacyListen to the latest episode of WCG Talks Trials to hear from experts on the importance of patient advocacy in clinical research and key takeaways from WCG's 2023 Patient Forum. We'll summarize how the patient forum elevates the voices of those changing drug development for the better and recap breakthroughs and best practices shared during the most recent event.Discover more about patient and researcher collaboration, expanding diversity, equity, and inclusion in trials, and the latest advocacy-driven technology, science, and policy breakthroughs leading to modernized clinical research. Guests:Desiree Underwood-Williams, PMP, CLSSBB, Director, P...
2023-11-1329 minWCG Talks TrialsThe Importance of Diversity, Equity, Inclusion, and Intersectionality in Clinical ResearchListen to the latest episode of WCG Talks Trials to hear from experts on the importance of diversity, equity, and inclusion in clinical research and how intersectionality plays a role in promoting DE&I. We'll discuss why diversity is pivotal for comprehending the full spectrum of clinical care mechanisms and review effective DE&I strategies being deployed today. Discover how communities can be more actively engaged in clinical research and hear real-world examples of success stories in promoting diversity, equity, and inclusion within clinical research.Moderator:Scott J. Hunter, PhD - Senior Scientific Expert, Neurodevelopmental and...
2023-10-2736 minWCG Talks TrialsDelve into the World of Psychedelic Research and Ethical InquiryJoin WCG Talks Trials podcast host Kelly Fitzgerald, PhD, in a riveting dialogue with guest expert Currien MacDonald, MD, as they unravel the nuances of "Psychedelics in Research: Ethical and Medical Perspectives." Dr. MacDonald, with a solid foundation in family medicine and clinical trials administration, guides listeners through a grounded exploration of psychedelic substances. In this episode, they demystify the realm of psychedelics, encompassing both dissociative and classic varieties, such as LSD and MDMA. As the conversation delves into ongoing research, the potential applications of these compounds in treating mental health challenges like depression, anxiety, an...
2023-09-2625 minWCG Talks TrialsA 360-degree View on Motivators and Deterrents to Clinical Trial ParticipationIn episode three of WCG Talks Trials, two WCG experts discuss key findings from the 2023 Avoca State of the Industry Report, which provides a 360-degree view on motivators and deterrents to clinical trial participation.Listen in as we dive into feedback from perspectives across all clinical research stakeholders — sponsors, providers, sites, and patients — for valuable take-aways and insights into the trial experience.Speakers:Crissy MacDonald, PhD, Vice President, Client Delivery, WCG AvocaGina DiCindio, Associate Director, Industry and Client Research, WCG Avoca
2023-09-1130 minWCG Talks TrialsBreaking Down Enrollment Barriers: How DE&I, Technology, and Protocol Design Impact Enrollment SuccessIn episode two of WCG Talks Trials, we are joined by two WCG experts to discuss overcoming common enrollment challenges and how DE&I, technology, and protocol design factor into enrollment success.Listen in as we delve into the critical topic of common enrollment barriers in clinical trials, how to improve enrollment by focusing on DE&I efforts, the importance of site-centric and patient-centric technologies, and how thoughtful protocol design plays a significant role in enrollment success.Speakers:Dawn Sauro, Chief Growth Officer, WCGJamie Harper, MHA, CCRP - Vice President, Site Solutions...
2023-08-1618 minWCG Talks TrialsUnlocking Site Potential: Reducing Site Burden and Enhancing Clinical Trial EfficiencyIn the first episode of our new podcast series, WCG Talks Trials, we are joined by three industry experts, Lisa Ballance from Virginia Commonwealth University, John Musser from Florida Cancer Specialists and Research Institute, and Dan Otap from Genentech, to discuss the topic of overcoming site challenges and addressing site burden.Listen in as we discuss the results of WCG’s recently published 2023 Clinical Research Site Challenges Survey Report, gain insights from our guests on solutions their organizations have implemented to reduce site burden, and share perspectives on how sites, sponsors, and CROs can work to improve si...
2023-07-1635 min
WCG BizcastCRNA: Tax Deductions | WCG Inc. | BizcastJason Watson, CPA, Joseph Bassett, EA, and Megan Oeltjenbruns, CPA, run through the common tax deductions that a CRNA can use as a 1099 contractor. What can be a business deduction and the rules that apply to getting that deduction.
Related Blog Posts:
https://wcginc.com/kb/home-office-deduction/
https://wcginc.com/kb/tax-free-rental-of-your-home/
https://wcginc.com/kb/automobiles-and-llcs-s-corps/
https://wcginc.com/business-services/s-corp-salary/
Visit WCG today at: https://wcginc.com/
---
Find us Online!
► Facebook: https://www.facebook.com/WCGIncCPA/
► LinkedIn: https://www.linkedin.com/company/wcginc
► Twitter: https://twitter.com/wcginccpa
► Instagram: https://www.instagram.com/wcginccpa/
2022-10-1726 minWCG BizcastCRNA: State Issues | WCG Inc. | BizcastJason Watson, CPA, Joseph Bassett, EA, and Megan Oeltjenbruns, CPA, continue their discussion on the CRNA industry. How doing business differs depending on the state you have your business registered in and where you do your business. The impact a state could have on your income taxes and payroll processing too.
Visit WCG today at: https://wcginc.com/
---
Find us Online!
► Facebook: https://www.facebook.com/WCGIncCPA/
► LinkedIn: https://www.linkedin.com/company/wcginc
► Twitter: https://twitter.com/wcginccpa
► Instagram: https://www.instagram.com/wcginccpa/
2022-10-1719 minWCG BizcastCRNA: W-2 and 1099 | WCG Inc. | BizcastJason Watson, CPA, Joseph Bassett, EA, and Megan Oeltjenbruns, CPA, discuss who a CRNA is and their industry. They break down the differences between a CRNA being a 1099 contractor or a W-2 employee and which gives a CRNA more money and more deductions.
Related Blog Post:
https://wcginc.com/business-formation-services/s-corp-election/
Visit WCG today at: https://wcginc.com/
---
Find us Online!
► Facebook: https://www.facebook.com/WCGIncCPA/
► LinkedIn: https://www.linkedin.com/company/wcginc
► Twitter: https://twitter.com/wcginccpa
► Instagram: https://www.instagram.com/wcginccpa/
2022-10-1708 minWCG BizcastCRNA: Business Entity Matters | WCG Inc. | BizcastJason Watson, CPA, Joseph Bassett, EA, and Megan Oeltjenbruns, CPA, talk about the type of business entity a CRNA should be set up as and why some states are easier than others to set up your business. The benefits of the S-Election.Why you could be wearing two hats now and how the election factors into your income.
Related Blog Post:
https://wcginc.com/kb/basic-business-entities/
Visit WCG today at: https://wcginc.com/
---
Find us Online!
► Facebook: https://www.facebook.com/WCGIncCPA/
► LinkedIn: https://www.linkedin.com/company/wcginc
► Twitter: https://twitter.com/wcginccpa
► Instagram: https://www.instagram.com/wcginccp
2022-10-1712 minWCG BizcastOur Ideal Client RelationshipsJason Watson, CPA, Jason Schneider, CPA, and Megan Oeltjenbruns, CPA, wrap up our series of bizcasts discussing WCG and what we have to offer those looking to join our team. They discuss the type of client engagements we are seeking as a firm.
Visit WCG today at: https://wcginc.com/
---
Find us Online!
► Facebook: https://www.facebook.com/WCGIncCPA/
► LinkedIn: https://www.linkedin.com/company/wcginc
► Twitter: https://twitter.com/wcginccpa
► Instagram: https://www.instagram.com/wcginccpa/
2021-07-1520 minWCG BizcastCulture at WCGJason Watson, CPA, Jason Schneider, CPA, and Megan Oeltjenbruns, CPA, discuss the culture at WCG for prospective employees looking for a new work family.
Visit WCG today at: https://wcginc.com/
---
Find us Online!
► Facebook: https://www.facebook.com/WCGIncCPA/
► LinkedIn: https://www.linkedin.com/company/wcginc
► Twitter: https://twitter.com/wcginccpa
► Instagram: https://www.instagram.com/wcginccpa/
2021-07-1517 minWCG BizcastChallenges at WCGJason Watson, CPA, Jason Schneider, CPA, and Megan Oeltjenbruns, CPA, discuss the challenges of our firm faces, internally and systemically, and why we are excited about them.
Visit WCG today at: https://wcginc.com/
---
Find us Online!
► Facebook: https://www.facebook.com/WCGIncCPA/
► LinkedIn: https://www.linkedin.com/company/wcginc
► Twitter: https://twitter.com/wcginccpa
► Instagram: https://www.instagram.com/wcginccpa/
2021-07-1517 minWCG BizcastHow to be Successful at WCGJason Watson, CPA, Jason Schneider, CPA, and Megan Oeltjenbruns, CPA, discuss what it takes to be successful at WCG and the positions that we are seeking to fill.
Visit WCG today at: https://wcginc.com/
---
Find us Online!
► Facebook: https://www.facebook.com/WCGIncCPA/
► LinkedIn: https://www.linkedin.com/company/wcginc
► Twitter: https://twitter.com/wcginccpa
► Instagram: https://www.instagram.com/wcginccpa/
2021-07-1515 minWCG BizcastLife and Leadership at WCGJason Watson, CPA, Jason Schneider, CPA and Megan Oeltjenbruns, CPA, discuss life at WCG. The leadership WCG is looking for and how two of our newest leaders have adapted to the merging of two CPA firms in the last year.
Visit WCG today at: https://wcginc.com/
---
Find us Online!
► Facebook: https://www.facebook.com/WCGIncCPA/
► LinkedIn: https://www.linkedin.com/company/wcginc
► Twitter: https://twitter.com/wcginccpa
► Instagram: https://www.instagram.com/wcginccpa/
2021-07-1517 minWCG Talks TrialsLisa LaLuna, Matchmaking to Save Lives: The Clinical Trial Search Tool for EveryoneFrom a career devoted to finding better ways to connect patient volunteers to clinical trials, Lisa LaLuna knows why the public needed an online search tool that is easier to use than the traditional methods of access. “Members of the public often want to find a trial to access the latest medicine, or help a family member, or just to participate as a healthy volunteer to further medical research. Pharmaceutical companies that run clinical trials of course want to enroll patients so their research can be successful. In spite of this mutual desire to work together, patients and...
2021-01-0809 min
WCG Talks TrialsOn the Future of Movement Disorder Trials: Part 4 of WCG’s Transforming CNS Trials SeriesMovement disorder trials have always been demanding. Now, sponsors face an additional challenge: How do you ensure data integrity in the era of remote clinical trials? In this podcast, Bob Dagher, MD, WCG MedAvante-ProPhase’s Chief Medical Officer, addresses this in conversation with Steve Smith, WCG President of Patient Advocacy. This is the fourth episode in our series, “Transforming CNS Trials During COVID-19—and Beyond.”Sponsors planning to restart movement disorder programs need to be clear-eyed and realistic, Dagher counsels. “When it comes to remote assessments, we have to be vigilant and aware of what we can do and als...
2020-10-2109 min
WCG Talks TrialsOn the Future of Depression Trials: Part 3 of WCG’s Transforming CNS Trials SeriesIn major depressive disorder, researchers have used remote assessments for decades. As a result, many of these studies have had an easier time adapting to the new clinical trial landscape. But that doesn’t mean they are pandemic-proof. So what are the critical success factors for clinical depression programs—especially now? In his conversation with WCG President of Patient Advocacy Steve Smith, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase offers his insights on the future of clinical depression trials. This is the third episode in our podcast series, “Transforming CNS Trials During COVID-1...
2020-09-3010 min
WCG Talks TrialsOn the Future of Schizophrenia Trials: Part 2 of WCG’s Transforming CNS Trials SeriesRemote assessments have become a necessity across CNS trials, but some areas are more complicated than others. Schizophrenia provides one such example; the risk of variability is high, and sponsors are concerned. In this podcast, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase, sits down with WCG President of Patient Advocacy Steve Smith to discuss the topic. This is the second episode in our podcast series, “Transforming CNS Trials During COVID-19—and Beyond.”PANSS—the gold standard rating scale for schizophrenia primary outcomes—is based largely on face-to-face interviews; it wasn’t developed for remote assessments...
2020-09-2110 min
WCG Talks TrialsThe Case for Centralized Monitoring: Optimizing Data Quality and Risk Management with Linda Sullivan and Steve YoungHow can CROs and sponsors detect potential problems and issues in clinical trial conduct and data quality? That’s one of the critical issues discussed in Steve Young’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Young, Chief Scientific Officer at CluePoint, discusses how risk-based quality management (RBQM) methodology, data analytics, and data surveillance are being utilized today to go beyond just ferreting out fraud. Now, Young says, clinical trial stakeholders are deploying advanced statistical engines to detect quality and data breaches in investigational studies. According to Young, while there are still instanc...
2020-08-3136 min
WCG Talks TrialsStriving for Reliability: Optimizing Patient Report Data through World-Class Design Management with Linda Sullivan, Nat Katz, and Art MoralesCan patients be trained to report their symptoms more accurately? That’s one of the key topics discussed in Nat Katz’s and Art Morales’ interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Katz, the Chief Science Officer of WCG-Analgesic Solutions and Morales, Vice President, Technology Solutions at WCG, assert that, with proper design and implementation, you can structure clinical trials, such as pain management studies, so that patients learn how to better report their symptoms. With proper training, patients learn to accurately report their symptoms, resulting in more reliable...
2020-08-2738 min
WCG Talks TrialsThe Upside of Centralized Monitoring During a Pandemic: Linda Sullivan, Duncan Hall, and Rachel Oakley on Optimizing Clinical Trials through Innovative RBQM TechnologyHow are clinical trial companies pivoting to implement Risk-Based Quality Management programs during the pandemic? That’s one of the deep dives explored in Duncan Hall’s and Rachel Oakley’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Hall, founder and CEO of Triumph Research Intelligence (TRI) and Oakley, Vice President of RBQM Services at TRI, note that, when the COVID-19 pandemic first hit, CROs and sites performed risk assessments on their existing studies. Then those organizations took advantage of innovative technology that had a key tool for optimizing clinical trials —...
2020-08-1941 min
WCG Talks TrialsGet Rid of Those Silos: Linda Sullivan, Artem Andrianov, and Johann Proeve on How To Optimize Clinical Trials through RBQMWhat’s the secret to success for implementing a world-class holistic approach to a Risk-Based Quality Management (RBQM) system? That’s one of the key topics from Artem Andrianov‘s and Johanna Proeve’s interview with Executive Director of WCG’s Metric Champion Consortium (MCC), Linda Sullivan, MBA. Andrianov, CEO, and Proeve, Chief Science Officer at Cyntegrity emphasize the importance of developing a clinical trial platform that enables your organization to manage the entire quality management cycle rather than continuing with traditional silo-based approaches. This comprehensive approach, they explain, enables pharmaceutical companies to become more efficient in reducing r...
2020-08-1742 min
WCG Talks TrialsTurning Insights Into Action: Linda Sullivan and Ken Getz on How Metrics and Benchmarking Provide a Path To Optimizing Clinical Trials"What impact does a remote clinical team operating model have on clinical trial performance?" That’s one of the hot topics from Ken Getz’s interview with Executive Director of WCG’s Metric Champion Consortium (MCC), Linda Sullivan, MBA. He describes several projects that the Tufts Center for the Study of Drug Development (Tufts CSDD) is currently working on; ones that will provide robust, data-driven analysis and strategic insights that help drug development professionals improve pharmaceutical R&D. Getz is the Deputy Director of Tufts CSDD and Professor at the Tufts University School of Medicine. At any given t...
2020-07-2934 min
WCG Talks TrialsNow Is the Time: Making Your Clinical Trial More ResilientIn this episode, host Linda Sullivan, MBA, Executive Director of WCG's Metric Champion Consortium (MCC) chats with Laurie Halloran, founder of the Halloran Consulting Group, about how she developed an on-demand drug development team that can fill in gaps in the clinical trial process for life science companies, whether these involve regulatory strategy or execution, or quality, clinical, or manufacturing issues. The COVID-19 pandemic has resulted in these companies having to pivot to more virtual experiences. At the beginning of the outbreak, she notes, her group organized town halls that made it clear to stakeholders that life science companies...
2020-07-2432 min
WCG Talks TrialsChristopher Gantz, Building Trust and minority enrollment in clinical trials at Thomas Jefferson Hospital in Philadelphia“Our research population should match our community population.” That’s one of the takeaways from Christopher Gantz’s interview with WCG President of Patient Advocacy Steve Smith. He describes several programs that help connect researchers with minority communities to increase engagement and access enrollment in clinical trials. Gantz is senior director of the Regional Liaison Office at the Sidney Kimmel Cancer Center (SKCC) at Thomas Jefferson Hospital in Philadelphia. Since 2005, he has worked on multiple clinical trials projects with recruitment goals ranging from 500 to 10,000 participants. He describes establishing an “honest broker network” and engagement of resources within the hospital...
2020-06-1221 min
WCG Talks TrialsPeople, Process and Technology: The Right Combination for Successful Expert CommitteesIndependent expert committees provide essential validation of clinical data. Without their insights, sponsors risk missed signals, conflicts of interest and costly delays. But establishing a successful expert committee can be tricky. It requires the right combination of people, process and technology. In this three-part podcast, Lakshmi Sundar, head of business transformation at WCG ACI Clinical, explores each of these with a WCG ACI expert.In the first part of the series, Bill Stedman, manager of member services, shares his perspective on the “people” aspect. He discusses how success rests on having the right combination of expertise. Then, Dr...
2020-06-0344 min
WCG Talks TrialsFrank Sasinowski, MS, MPH, JD Hymen Phelps & McNamara: Rare Disease Regulatory Transformation: 1983 AIDS Crisis to PresentDrug policy has transformed to bring transformative improvement to the way rare diseases are developed resulting in more FDA approved treatments.This transformation came about because of collaboration across stakeholders: patient advocates, the FDA, Congress, drug developers, researchers, and legal specialists. Profound change came in the mid 1980’s when AIDS activists, Rare Disease Activists, and others found ways to use policy to accelerate development of FDA approved treatments.Legal specialists Frank Sasinowski of Hymen Phelps and McNamara has always been a champion of the patient voice in legislative change, drug development policy, and FDA approvals.
2020-04-2837 min
WCG Talks TrialsThomas Farrington: Cancer Survivor’s Prostate Health Network gets African American Communities Talking About Prostate CancerIn this podcast, Thomas Farrington, founder of the Prostate Health Network, speaks with WCG President of Patient Advocacy Steve Smith.Mr. Farrington discusses his experience with the healthcare system, coupled with his own research on prostate cancer, which led him to become a vocal advocate for prostate cancer patients and survivors. His advocacy spans a wide range of approaches from educational seminars, a frequently-visited website, a theater production called Daddy’s Boy that is now on tour, and visits to legislators on Capitol Hill to help shape public policy for the benefit of people with this unmet me...
2020-04-2121 min
WCG Talks TrialsCOVID-19 Doesn’t Play Fair: What We Need to Understand About Racial DisparitiesThis episode takes on a topic from recent headlines--namely, the racial disparity in COVID-19 cases and deaths. Edith P. Mitchell, MD, MACP, FCPP, shares her insights on the causes of these health disparities and how they relate to the coronavirus. Contributing factors include less access to testing, lack of insurance and paid time off, underlying health conditions, and the spread of misinformation about the virus.She also touches on how racial disparities affect clinical research. “When I came to Philadelphia, we had only 7.8% participation by African Americans in clinical trials. Yet 45% of Philadelphia is African American. We ha...
2020-04-1523 min
WCG Talks TrialsDr. David Fajgenbaum, MD, Castleman’s Disease Survivor, Facing COVID-19 with Research, Action, and HopeIn this COVID-19 focused episode, Dr. David Fajgenbaum chats with President of WCG Patient Advocacy, Steve Smith, to talk about his journey as a medical researcher and patient of a rare disease and about the pandemic facing our daily lives. Known for his best-selling book, Chasing My Cure: Turning Hope Into Action, Dr. Fajgenbaum shares best practices for how everyone facing this crisis can get through these scary and trying times together as a community via hope, prayer, action, humor, and the ability to create silver linings. Their discussion also highlights the importance of social distancing for p...
2020-04-0123 min
WCG Talks TrialsTurning Passion Into a Career: Insights from a Physician and Industry Medical Director of AbbVie Pharmaceuticals, Charlotte Owens, MD, FACOGIn this episode, WCG’s President of Patient Advocacy, Steve Smith, talks with Dr. Charlotte Owens, MD, FACOG, Medical Director at AbbVie Pharmaceuticals, who works in the general medicine therapeutic area with a focus on women’s health. As a physician, Dr. Owens describes her passion for pursuing a career that’s truly helpful for others and her desire to educate women on how to bring healthy children into the world. As her career grew into the clinical trials industry, Dr. Owens shares how this passion for helping others grew simultaneously, especially as she saw how bringing new drugs and th...
2020-02-2422 min
WCG Talks TrialsBiostatistics and Biomarkers for the Reliability and Efficiency of Clinical Trials: A Conversation with Dr. Janet WittesIn this episode, Dr. Janet Wittes, Founder and President of WCG Statistics Collaborative sits down with WCG’s President of Patient Advocacy, Steve Smith. Their conversation focuses on the importance of reliability and efficiency in clinical trials, and how biostatisticians work closely with clinicians and patients to help ensure clear results from trials. Moreover, they dive into how biomarkers can serve as surrogate endpoints for a trial, especially in the case of rare disease studies.
2020-02-1315 min
WCG Talks TrialsAn Inside Look at the Role of Data Monitoring Committees with Dr. Jonathan SeltzerIn this episode, WCG’s President of Patient Advocacy, Steve Smith, interviews Dr. Jonathan Seltzer, MD, Chief Scientific Officer at WCG, expert on data safety monitoring boards, biomarkers, biostatistics, and clinical endpoints. During their conversation, Steve and Dr. Seltzer discuss how biomarkers are appropriate for the use of trials, especially when clinical data is tough to get. Part of this discussion turns to Duchenne’s Muscular Dystrophy (an inherited rare muscular disease) on how Patient Advocacy Groups are working with the FDA to define risk vs. benefit, and how promising a biomarker for this condition - as well as many...
2020-02-1318 min
WCG Talks TrialsAn Interview with Dr. Jeffrey Cooper: Clinical Trial Expert and ParticipantIn this episode, WCG’s President of Patient Advocacy, Steve Smith, interviews Dr. Jeffrey Cooper, MD, MMM, Vice President of Process & Strategic Improvement at WCG, expert in the conduct of clinical trials, and Parkinson’s patient himself. During their conversation, Steve and Dr. Cooper highlight the strides clinical research has made for many therapeutic areas and the promise research has for individuals across the globe. With a specific focus on Parkinson’s disease, Dr. Cooper dives into his journey as a clinical trial participant and shares his experience on finding a trial, getting enrolled into the study, and his time s...
2020-02-1017 min
WCG Talks TrialsJulia Jenkins, EveryLife Foundation for Rare Diseases: Patient’s shape science-driven public policyIn this episode, Steve Smith, WCG President of Patient Advocacy sits down with Julia Jenkins of the EveryLife Foundation to discuss the impact her organization has on giving patients a voice to legislators on Capitol Hill. Julia shares how patient communities can advocate for public policy changes, improve the FDA-regulatory approval process, and educate on the effectiveness of different trial designs for rare disease drug development. Through their conversation, Steve and Julia underscore the importance of collaboration between all clinical trial stakeholders to improve the study process.
2020-02-1019 min
WCG Talks TrialsEnsuring Genetic Counseling is Incorporated Into the Patient Experience: An Interview with Sarah Zentack & Leslie UrdanetaIn this episode, WCG’s President of Patient Advocacy, Steve Smith, sits down with Sarah Zentack, a Certified Genetic Counselor at InformedDNA and Leslie Urdaneta, Family Support Coordinator at the National MPS Society. Their discussion highlights the importance of genetic counseling and the intelligence patients can gain to better understand their treatment options, ensure they’re receiving the correct information and interpretation of results, and feel empowered to make the right choices for their care options.
2020-01-1321 min
WCG Talks TrialsSarah Tompkins, on Having Ehlers-Danlos Syndrome, Having a Mis-Understood Disease, and Taking a Lead in AdvocacyIn this episode, Sarah Tompkins, Patient Advocate of Ehlers-Danlos Syndrome, chats with WCG’s President of Patient Advocacy, Steve Smith. During their discussion, Sarah shares with us her experience being a patient with a genetic rare disease who is involved in a clinical trial.
2020-01-1322 min
WCG Talks TrialsDeveloping Novel Treatments for Rare Disorders: A Look at MPS I with Dr. Emil KakkisIn this episode, WCG’s President of Patient Advocacy, Steve Smith, talks with Emil Kakkis, MD, PhD, Chief Executive Officer of Ultragenyx Pharmaceuticals and President of the non-profit EveryLife Foundation for Rare Diseases organization. Known for his work in developing an enzyme replacement therapy for the rare disorder MPS I and his connection to the Ryan Foundation, Dr. Kakkis shares with us his experiences in being involved in bringing drugs to market and forming relationships with patients along the way.
2020-01-1319 min
WCG Talks TrialsBlazing New Trails in Rare Disease & CNS Clinical Studies: An Interview with Dr. Mark OplerIn this episode, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase sits down with Steve Smith, WCG’s President of Patient Advocacy to discuss the achievements in the field of CNS and rare disease clinical research. Dr. Opler and Steve highlight the unmet need of therapies available for rare disease, the importance of patient enrollment, ensuring efficacy and safety throughout a trial, and how time is of the essence in every study that is conducted.
2020-01-1320 min
WCG Talks TrialsAn Inside Look at Angelman Syndrome Rare Disease: An Interview with Amanda MooreIn this episode, Amanda Moore, CEO of Angelman Syndrome Foundation speaks with Steve Smith, WCG’s President of Patient Advocacy. As a mom whose son has been diagnosed with Angelman Syndrome - a rare neuro-genetic disorder that affects 1 in 15,000 children - Amanda walks through the time from receiving initial diagnosis to the odyssey of her son’s patient journey in therapy and clinical trials.
2020-01-1318 min
WCG Talks TrialsThe Role and Importance of Genetic Counselors to Patients: An Interview with Karmen Trzupek of InformedDNAIn this episode, Karmen Trzupek, MS, CGC, Director of Ocular & Rare Disease Genetic Services and Clinical Trial Services at InformedDNA sits down with WCG’s President of Patient Advocacy, Steve Smith. During their conversation, Karmen and Steve talk about the criticality of incorporating genetic counselors into the medical management of a patient’s genetic diagnosis.
2020-01-1318 min
WCG Talks TrialsLearning How to See Differently: An Interview with Kristin Smedley, President of the Curing Retinal Blindness FoundationIn this episode, Kristin Smedley sits down with President of WCG Patient Advocacy, Steve Smith, to talk about the journey her two children with retinal blindness have experienced. Known as the “happiest mom of two blind kids” and a powerful TEDx talker, Kristin highlights the CRB1 rare genetic degenerative disease both of her boys are affected with. She underscores the importance of genetic diagnosis and shares the impact clinical trials and patient advocacy groups have had in finding a cure for this disease.
2020-01-1320 min
WCG Talks TrialsMark Dant, Pushing for Research that Saved His Son’s Life in the Fight Against MPS IIn this episode, Mark Dant, Founder of the Ryan Foundation speaks with Steve Smith, WCG’s President of Patient Advocacy. Their conversation highlights the importance of Patient Advocacy Groups – and the resources they bring to individuals diagnosed with a disease – as well as the great promise clinical trials bring to patients. Mark shares a personal story of his son, Ryan, who was diagnosed with MPS I, and how Patient Advocacy Groups and clinical trials have positively impacted their lives.
2020-01-1324 min
WCG BizcastBourbon and Business | Business Tax Deductions Part 200;00;14;09 [Jason]: Jason Watson with WCG Incorporated here in ColoradoSprings, we're a local tax and accounting firm. Joined by RachaelWeber and Joseph Bassett, both tax professionals for us. We'realso hosted by Axe and the Oak here in Colorado Springs, they'vebeen gracious enough to open up early for us, part of our Bourbonand Business00;00;31;29 series, podcasts and videos. We just got done wrapping up a videoand podcast on some of the bigger deductions that we see, cars,that's always...
2020-01-0700 min
WCG BizcastBourbon and Business | Business Tax Deductions Part 1In this episode of our Bourbon and Business series, Jason Watson, CPA, sits down with Rachael Weber and Joseph Bassett of WCG Inc (formerly Watson CPA Group) to chat about our favorite part of tax season - tax deductions! The three most popular being car, meals, and travel deductions for both personal and business use. Stay tuned for part 2 of Business Tax Deductions, where we delve into the "odds and ends" deductions like your home office and country club dues! This material is based on content from our website and our book, Taxpayer’s Comprehensive Guide to LLC...
2020-01-0700 min
WCG BizcastBourbon and Business | Business Financial Planning Part 2In this second segment on Business Financial Planning, Jason Watson, CPA, sits down with Bud Rainsberger of RWA Partners in Colorado Springs to continue their discussion about when, why, and how to sell your small business. Bud explains the importance of understanding your motivation for selling, and, he touches on the emotionality of the decision and how it can impact your personal and professional life going forward. Special thanks go to Axe and the Oak Distillery for graciously hosting our Bourbon and Business podcast series! This material is based on content from our website and our book, Taxpayer’s Co...
2019-12-3000 min
WCG BizcastBourbon and Business | Business Financial Planning Part 1In this first segment about Business Financial Planning, Jason Watson, CPA, sits down with Bud Rainsberger of RWA Partners in Colorado Springs to discuss the importance of having a well-defined plan for your business investments. Topics covered include; when to sell or not sell your business, how much cash are you taking out of the business, and how personal interests can compete with business interests. Special thanks go to Axe and the Oak Distillery for graciously hosting our Bourbon and Business podcast series! This material is based on content from our website and our book, Taxpayer’s Com...
2019-12-2300 min
WCG BizcastBourbon and Business | Marijuana BankingIn this Bourbon and Business podcast episode, Jason Watson, CPA, and Quentin Leighty, President of First National Bank in Monument, Colorado, discuss the controversial issue of Marijuana Banking. Quentin sheds light on the gray areas of banking regulations at the Federal and State level, and, offers insight about the recently passed SAFE Banking Act, which protects financial institutions in legalized states that want to offer banking services to MMJ businesses. Special Thanks to Axe and the Oak Distillery for hosting our Bourbon and Business series!This material is based on content from our website and our book...
2019-12-2300 min
WCG BizcastBourbon and Business | Business Banking Part 2In segment #2 of Business Banking, Jason Watson, CPA, and Quentin Leighty, President of First National Bank in Monument, Colorado, continue their discussion about how to qualify for small business loans. Topics in this episode cover basic business lending options including collateralization, business acquisition lending, IRA loans, and SBA loans. Special thanks to Axe and the Oak Distillery for hosting our Bourbon and Business podcast series!!This material is based on content from our website and our book, Taxpayer’s Comprehensive Guide to LLCs and S Corps. https://wcginc.com/kb/operating-agree...https://wcginc.com...
2019-12-1600 min
WCG BizcastBourbon and Business | Business Banking Part 1In this first segment about Business Banking, Jason Watson, CPA sits down with Quentin Leighty, President of First National Bank in Monument, Colorado, to discuss the pros of small business owners utilizing community banking vs. going to the "big banks" to finance a business and the perks of relationship-based models for banking. Special thanks go to Axe and the Oak Distillery for graciously hosting our Bourbon and Business podcast series!This material is based on content from our website and our book, Taxpayer’s Comprehensive Guide to LLCs and S Corps. https://wcginc.com/kb/ope...
2019-12-0900 min
WCG Talks TrialsChasing My Cure: an Interview with Dr. FajgenbaumIn this episode, WCG’s President of Patient Advocacy, Steve Smith, sits down for an interview with Dr. David Fajgenbaum, Assistant Professor of Medicine at the University of Pennsylvania and Author of Chasing My Cure: A Doctor’s Race to Turn Hope Into Action. In this podcast, you’ll hear Steve and Dr. Fajgenbaum discuss what it’s like to be a patient of a rare disease – in this case Castleman’s disease – and Dr. Fajgenbaum’s fight to find a cure for his own disease. This is a story of incredible courage and uniquely acquired wisdom. It is a story of trium...
2019-11-1837 min
WCG BizcastTax Preparation ProcessJason Watson, CPA, of WCG Inc. (formerly the Watson CPA Group) with Amanda Rowles and Joseph Bassett discuss WCG's tax preparation process including safely handling your tax documents through our secure client portal and checklists to ensure completeness. They also discuss the turn-around time and how WCG interfaces with the client for missing information or clarifications.The episode concludes with tax return reviews, tax filing deadlines and tax return extensions.This material is based on content from our website and our book, Taxpayer’s Comprehensive Guide to LLCs and S Corps.https://wcginc.co...
2019-10-2600 min
WCG BizcastOperating Your S CorporationJason Watson, CPA, of WCG Inc. (formerly the Watson CPA Group) with Amanda Rowles and Joseph Bassett discuss the housekeeping of operating an S Corporation. Issues reviewed are tax planning including all household income sources ending in mock tax returns. They also discuss Periodic Business Reviews (PBRs) and WCG's model of unlimited business consultation.They also review the tax filing deadlines for business returns (S Corps and Partnerships are March 15 whereas C Corporations are April 15). And! Just because pass-thru entities do not have an income tax obligation at the federal level, there might be state issues; that...
2019-10-2600 min
WCG BizcastLate S Corp ElectionJason Watson, CPA, of WCG Inc. (formerly the Watson CPA Group) with Amanda Rowles and Joseph Bassett review the S Corp benefits, reduction of self-employment taxes and the whole S Corp vs LLC discussion. But! The crux of this episode is how to retroactively file for a late S Corp election using Form 2553 and IRS Rev Proc 2013-30.Then this episode discusses the timing of the late S Corp election and how it impacts tax return filing deadlines, extensions, late payroll events, and other pitfalls. Here is a spoiler alert- filing a S corporation election is a...
2019-10-2600 min
WCG BizcastS Corp ElectionJason Watson, CPA, of WCG Inc. (formerly the Watson CPA Group) with Amanda Rowles and Joseph Bassett discuss the S Corp tax benefits versus the garden-variety LLC. The S Corp vs LLC discussion starts with general S Corp benefits, but does a deeper dive into reducing self-employment taxes and lowering audit rate risk.They also review the Does It Make Sense questions such as-Does your business earn over $30,000 net income after expenses? Say Yes.Are you located in New York City or Tennessee where S corporation tax rates are egregious and suck...
2019-10-2600 min
WCG BizcastEntity Formations and ConsiderationsThe Entity Formations and Considerations podcast by WCG Inc. (formerly the Watson CPA Group) explores basic business entity considerations such physical nexus, economic nexus, LLCs versus corporations, and how this impacts professionals such as attorneys, physicians, accountants, engineers, etc. plus adding other members such as a spouse or children. We also touch lightly on the benefits of an S Corp but we also have a full-blown podcast on that topic alone (stay tuned).This podcast pulls from our book, Taxpayer's Comprehensive Guide to LLCs and S Corps, which is available on our website at-https...
2019-09-2600 min
WCG Talks TrialsThe State of Clinical Trials in Autism and Neurodevelopmental Disorders with Dr. Scott HunterWhat’s the state of clinical trials in autism and neurodevelopmental disorders? What’s on the horizon?Scott J. Hunter, PhD, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with Mark Opler, MD, PhD, Chief Research Officer at WCG-MedAvante-ProPhase. Dr. Hunter is a professor of psychiatry and behavioral neuroscience, as well as pediatrics, at the University of Chicago.
2019-08-1322 minWCG Talks TrialsThe New Paradigm of Patient Recruitment: an interview with Mark SummersDespite advances in science and technology, we still see that 80% of clinical trials are running behind on their enrollment timeline.Mark Summers, Founder of WCG ThreeWire, and President of Patient Engagement at WCG, shares his insights on the current industry model of patient recruitment and the philosophy behind the new patient recruitment paradigm. Things you will learn in this podcast:Shortcomings of the current industry model of patient recruitmentHow to better plan for and deploy patient recruitment strategiesHow to find the most reliable and resource effective patientsThe economic philosophy of planning and...
2019-07-0518 min
WCG Talks TrialsExciting Developments in Psychopharmacology with guest Andrew Cutler, MDDr. Andrew J. Cutler shares his insights on the current challenges and opportunities for CNS therapies during an energizing conversation with Dr. Mark Opler, Chief Research Officer at WCG MedAvante-ProPhase.Dr. Cutler is a member of WCG’s Scientific Leadership Team, and a recognized expert in CNS therapies and clinical trials. Dr. Cutler is a sought-after speaker about the evaluation and treatment of mental illnesses such as ADHD, Bipolar Disorder (Manic-Depression), Major Depression, Anxiety Disorders and Schizophrenia. He conducts clinical trials for Phase I-IV studies. Indications include ADHD in children, adolescents and adults, depression, anxiety, bipolar disorder, sc...
2019-05-0325 minWCG Talks TrialsThe Role of Expert Committees in Clinical Research with guest Jonathan Seltzer, MD, MBA, MA, FACCDr. Seltzer, president and founder of ACI Clinical, and chief scientific officer of WCG Clinical, shared his insights on expert committees during a recent conversation with Bill Stedman, manager, member services, ACI Clinical.
2019-04-2813 min
WCG Talks TrialsThe Most Pressing Challenges and Opportunities in Pain Research with guest Nathaniel Katz, MD, MSDr. Katz, Chief Science Officer and the founder of Analgesic Solutions, shared his insights during a recent conversation with Mark Opler, MD, PhD, Chief Research Officer at WCG’s MedAvante-ProPhase. WCG recently acquired Analgesic Solutions.
2019-04-1919 min
WCG Talks TrialsImportant Trends in CNS Clinical Trials with guest Cristoph Correll, MDChristoph U. Correll, MD, a member of WCG’s Scientific Leadership Team, shared his thoughts in a recent conversation with Mark Opler, MD, PhD, chief research officer at WCG-MedAvante-ProPhase. Dr. Correll is both a clinical psychiatrist (for both adults and children) and a clinical scientist. His work focuses on the identification, characterization and treatment of adults and youths with severe psychiatric disorders. His particular area of expertise is psychopharmacology.
2019-03-2714 min
WCG Talks TrialsThe Most Pressing Challenges in Psychiatry Clinical Trials with Leslie Citrome, MD, MPHLeslie Citrome, MD, MPH, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with Mark Opler, MD, PhD, chief research officer at WCG-MedAvante-ProPhase. Dr. Citrome has a private practice and is clinical professor of psychiatry and behavioral sciences at New York Medical College in Valhalla.
2019-03-0614 min